tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

EBS Stock Latest News

Positive Outlook for Emergent Biosolutions: Buy Rating Supported by Strong Contract Wins and Financial Recovery
RatingsPositive Outlook for Emergent Biosolutions: Buy Rating Supported by Strong Contract Wins and Financial Recovery
3h ago
EBS
Emergent BioSolutions Reports Strong 2024 Financial Turnaround
PremiumCompany Announcements
Emergent BioSolutions Reports Strong 2024 Financial Turnaround
10h ago
EBS
Closing Bell Movers: Okta spikes 15% on earnings beat and outlook
PremiumThe Fly
Closing Bell Movers: Okta spikes 15% on earnings beat and outlook
15h ago
GO
DSP
Emergent BioSolutions Reports 2024 Financial Results
PremiumCompany Announcements
Emergent BioSolutions Reports 2024 Financial Results
16h ago
8K
EBS
Emergent BioSolutions sees Q1 revenue $200M-$240M, consensus $279M
PremiumThe Fly
Emergent BioSolutions sees Q1 revenue $200M-$240M, consensus $279M
16h ago
EBS
Emergent BioSolutions reports Q4 adjusted EPS 5c, consensus (50c)
PremiumThe FlyEmergent BioSolutions reports Q4 adjusted EPS 5c, consensus (50c)
17h ago
EBS
Emergent BioSolutions sees FY25 revenue $750M-$850M, consensus $1.13B
Premium
The Fly
Emergent BioSolutions sees FY25 revenue $750M-$850M, consensus $1.13B
17h ago
EBS
Mpox strain with higher transmission rate detected in Congo, Bloomberg reports
Premium
The Fly
Mpox strain with higher transmission rate detected in Congo, Bloomberg reports
5d ago
EBS
GOVX
Is EBS a Buy, Before Earnings?
PremiumPre-Earnings
Is EBS a Buy, Before Earnings?
14d ago
EBS
Emergent BioSolutions, Smith raise awareness on opioid poisonings
PremiumThe Fly
Emergent BioSolutions, Smith raise awareness on opioid poisonings
25d ago
EBS
Emergent BioSolutions starts enrollment in Africa or cDC-led MPox study
PremiumThe Fly
Emergent BioSolutions starts enrollment in Africa or cDC-led MPox study
2M ago
EBS
Emergent BioSolutions Outlines Growth at J.P. Morgan Conference
PremiumCompany Announcements
Emergent BioSolutions Outlines Growth at J.P. Morgan Conference
2M ago
8K
EBS
Emergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal spray
PremiumThe FlyEmergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal spray
2M ago
EBS
Emergent BioSolutions gains exclusive commercial rights to KLOXXADO
Premium
The Fly
Emergent BioSolutions gains exclusive commercial rights to KLOXXADO
2M ago
EBS
Emergent BioSolutions receives contract option valued at $16.7M
Premium
The Fly
Emergent BioSolutions receives contract option valued at $16.7M
2M ago
EBS
Emergent BioSolutions exercises $20M option to supply DoD with BioThrax
PremiumThe Fly
Emergent BioSolutions exercises $20M option to supply DoD with BioThrax
2M ago
EBS
Emergent BioSolutions rises 5.3%
PremiumThe Fly
Emergent BioSolutions rises 5.3%
2M ago
EBS
Emergent BioSolutions initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Emergent BioSolutions initiated with a Buy at H.C. Wainwright
2M ago
EBS
Mpox spreading in Congo’s capital, NY Times reports
PremiumThe Fly
Mpox spreading in Congo’s capital, NY Times reports
2M ago
EBS
GOVX
Emergent BioSolutions receives $50M contract option from BARDA
PremiumThe FlyEmergent BioSolutions receives $50M contract option from BARDA
3M ago
EBS
WHO determines mpox upsurge still constitutes public health emergency
Premium
The Fly
WHO determines mpox upsurge still constitutes public health emergency
3M ago
EBS
GOVX
Emergent BioSolutions files to sell 3.61M shares of common stock for holders
Premium
The Fly
Emergent BioSolutions files to sell 3.61M shares of common stock for holders
4M ago
EBS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >